Current Situation on Application of Evidence-Based Pharmacy in National Drug Policy

Linan Zeng; Dan Liu; Lingli Zhang; Wei Xiao; Zhe Chen; Hailong Li; Sha Diao; Kun Zou; Qiusha Yi

doi:10.1111/jebm.70033

Journal of Evidence-Based Medicine ›› 2025, Vol. 18 ›› Issue (2) : e70033 DOI: 10.1111/jebm.70033

EDITORIAL

Current Situation on Application of Evidence-Based Pharmacy in National Drug Policy

Linan Zeng ¹^,²^,³^,⁴
, Dan Liu ¹^,²^,³^,⁴
, Lingli Zhang ¹^,²^,³^,⁴^,⁵
, Wei Xiao ¹^,²^,³^,⁴^,⁶
, Zhe Chen ¹^,²^,³^,⁴
, Hailong Li ¹^,²^,³^,⁴
, Sha Diao ¹^,²^,³^,⁴
, Kun Zou ¹^,²^,³^,⁴
, Qiusha Yi ¹^,²^,³^,⁴

Author information +

History +

PDF

Cite this article

Download citation ▾

Linan Zeng, Dan Liu, Lingli Zhang, Wei Xiao, Zhe Chen, Hailong Li, Sha Diao, Kun Zou, Qiusha Yi. Current Situation on Application of Evidence-Based Pharmacy in National Drug Policy. Journal of Evidence-Based Medicine, 2025, 18(2): e70033 DOI:10.1111/jebm.70033